These are the 13 key Rapamycin studies and trials to keep an extra eye on and which will publish lots of interesting longevity data within the near future. The new one in the list is the LONGER trial. It is submitted for ethics approval and is led by the longevity researcher Ajla Hodzic in Singapore under Andrea Maier.
